BiotechTube
Home/Pipeline/RG002 (RG002-01)

RG002 (RG002-01)

HPV-associated HSIL / Persistent Infection / Cancer

Phase 1/IIaActive (Recruitment Completed per website timeline)

Key Facts

Indication
HPV-associated HSIL / Persistent Infection / Cancer
Phase
Phase 1/IIa
Status
Active (Recruitment Completed per website timeline)
Company
RinuaGene Biotechnology

About RinuaGene Biotechnology

A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.

View full company profile

Therapeutic Areas

OncologyInfectious DiseaseRare Disease

Other HPV-associated HSIL / Persistent Infection / Cancer Drugs

DrugCompanyPhase
RG002-02RinuaGene BiotechnologyPreclinical
RG002-04RinuaGene BiotechnologyPreclinical